Home NDC 78206-162 Renflexis
Product NDC 78206-162
11-digit product format 782060162
Labeler code 78206
Product ID 78206-162_ae5aa866-45c5-4dd8-ace4-cabe72994604
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name infliximab
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Organon LLC
Application BLA761054
Marketing category BLA
Marketing start 2017-04-21
Substance INFLIXIMAB
Active strength 100 mg/1
Pharmacologic classes Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Renflexis
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength INFLIXIMAB 100 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination B72HH48FLU Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1927285 Internal RxNorm lookup 1927290 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 78206-162-01 Renflexis 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 6 78206-162-99 Renflexis 1 in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 1 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 78206-162 RENFLEXIS (INFLIXIMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ORGANON LLC] 3 Current NDC, Legacy NDC, 2 package rows 20240110_dbf738c4-3fac-4422-a9d8-51d9c83a8789.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761054 Renflexis infliximab-abda 351(k) Biosimilar Rx 2026-08-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 78206-162-01 78206016201 1 VIAL in 1 CARTON (78206-162-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (78206-162-99) 1 vial 2021-06-01 0000-00-00 No No Current 78206-162-99 78206016299 1 in 1 VIAL Historical